Metabolic Syndrome 2016: a forgotten or existing entity?

Abstract

Metabolic syndrome is a premorbid situation, a constellation of metabolic risk factors and defines the need for clinical treatment of obese who have multiple additional risk factors. Nowadays there is a tendency of evolution of metabolic syndrome in a syndrome of renal, cardiac and vascular indices which contribute to atherosclerosis and exacerbate vascular endothelial dysfunction. Metabolic syndrome cannot be considered as a predictor in cardiovascular risk assessment models with a short study period (e.g., 10-year risk). The presence of metabolic syndrome is closely linked with an increased risk of diabetes and cardiovascular disease development. It is also associated with the urgent need to assess the overall cardiovascular risk and the presence of subclinical atherosclerosis by noninvasive imaging. Metabolic syndrome can bring together the fields of cardiovascular disease and diabetes in an effort to limit the risks of both aforementioned situations.

Keywords

• metabolic syndrome
• diabetes